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Abstract 
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1 Introduction. 
In the field of interim monitoring of clinical trials, a group-sequential alternative to the 
decision-theoretic fully-sequential procedures of Berry ( 1985) has been forcefully advocated 
by Geisser (1992, 1993a) and further developed in collaborative work with Johnson (1993). 
Noting the difficulties clinical researchers have experienced in specifying an appropriate loss 
function and defining the relevant patient horizon, Geisser & Johnson recommended that a 
Bayesian predictive stance be adopted instead, close in spirit to the stochastic curtailment 
ideas of DeMets & Lan (1984), Choi & Pepple (1989) and Spiegelhalter et al. (1986, 1988). 
The syncretic approach favored by this latter group - a combination of significance testing 
at the terminal decision point with Bayesian analysis at the interim point - was found 
wanting, however, and was discarded in favor of a fully Bayesian treatment of the problem. 
An overview of recent work on this topic is provided by Geisser {1993b ). 
The setup of most interest to us is one where a laboratory or regulatory agency is 
evaluating a new thera.py and stipula.tes that a decision on its effectiveness cannot be made 
unless data becomes available on at least s subjects, at which point it may be decided 
that it is at least as effective as some standard, it is found ineffective or it is deemed 
sufficiently promising to justify further sampling. We assume that the problem can be put 
in a parametric framework - with g( 8) a scalar function of the parameters indicative of the 
effectiveness of the treatment - and that a prior can be elicited for g( 8) or an uninformative 
analysis can be agreed upon. The final decision after seeing data y s can then be made 
dependent upon Ps = P[g(B) E GI Ys], the probability content of an appropriately chosen 
credible set G in the support of g( 9) I y 8 • The treatment would then be declared effective if 
Ps exceeded P2, the trial abandoned if Ps fell below p1 or a decision withheld for Ps E [p1 , p2]. 
The minimum-sample-size requirement s is assumed to have arisen from a fixed de-
sign minim.is~ng_ some preposterior measure of loss, when a reasonable loss function can be 
specified. Alternatively, s could be the maximiser of the Kullback-Leibler (KL) divergence 
between the prior and posterior density of the parameters of interest, subject to a fixed 
budget for the experiment. Proposed by Lindley (1956) and given additional theoretical 
justification by Bernardo (1979), KL divergence is a natural measure of the information 
provided by the data and has recently been put forward as a design criterion for clinical 
trials by Parmigiani & Berry (1994). It is often equivalent to maximising the probability 
content of select credible sets of the terminal posterior, an ad-hoc criterion one can also use 
directly as an easier-to-interp1·et design goal. 
Since sampling is costly, the experimenter may want to take a training sample of size 
n~ s first and use Pn as a rough guide to what Ps will turn out to be, before entering 
an additional m~ s - n subjects into the study. But, the differences between the interim 
and terminal posterior probabilities may well be substantial and it is more appropriate to 
examine the predictive distribution of Ps given the interim data. Complicated to start with, 
the evaluation of this quantity becomes harder if uncertainty about the accrual rate of future 
entrants to the study is to be taken into account and allowance made for censoring in both 
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the present and future sample. Fast and accurate approximations to this quantity are thus 
essential to the implementation of the Bayesian approach. In this paper, we limit ourselves 
to the implementation and evaluation of Bayesian predictive stopping rules for loglifetime 
data arising from linear regression models with uninformative censoring and arbitrary, but 
known, error distributions. 
We mention in passing that the Bayesian predictive approach can also be of use in 
clinical investigations whose purpose is not tied to a specific decision, but which aim rather 
to "contribute usefully to knowledge", a shift of emphasis designed partly to accommodate 
Armitage's (1989) criticism of early-stopping rules. In a trial "to learn", a specified increase 
in information may itself be the primary goal and the aim of the interim analysis would 
then be to ascertain the probability that this goal will be reached eventually, subject to the 
aforementioned budget and time limitations. 
2 Is a detailed predictive analysis worthwhile? 
When the accrual rate is deterministic and observation of all n individuals in the initial 
sample ceases at the interim point, the quantity of interest to us is of the form 
P[P[g(8) E GIYn+mJ ~ PIYn] = P[Pn+m ~ PIYn], (2.1) 
Its evaluation at p1 , P2 allows us to calculate at the interim point the probability that either 
one of the three possible decisions will eventually be reached after termination of the study. 
If P [ Pn+m ~ P2 I y n ] falls below some lower bound chosen to reflect the losses of correct 
and incorrect decisions, we may well decide to abandon the trial early, rather than commit 
more resources in an apparently futile effort to demonstrate a treatment effect. By allowing 
m + n to exceed the minimum sample size s, we can also conduct a sensitivity analysis of 
the type deseribed in Geisser (1993a) . 
.Although (2.1) seems a reasonable quantity to examine in this context, its evaluation 
can sometimes be avoided altogether, since we can bound it both above and below. In 
order to do this, let us first denote by (n, F, Q) the common probability space on which 
8, y1, y2, ... are defined and set Fk = u(y1, ..• , Yk), Foo= u(U~1 Fk)-
If A = { w : g o 9 ( w) E G}, we see that 
Pn+m = P[g(8) E GI Yn+m] = E[JA I Fn+m] 
is but the conditional expectation of a bounded function of w. Since 
(2.2) 
the sequence is a martingale and converges a.s. Q and in mean square to E[ IA I Foo] as m 
increases, by sec. VII ofDoob (1953). When IA is F00 measurable, IA itself is the limit a.s Q. 
Doob's proof does not make transparent the dependence of the convergence set on the prior. 
This is clearer in an earlier paper of Doob (1949), which pertains to the more restrictive case 
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of i.i.d sequences of observations with proper priors on the parameters. There it is seen that 
the set of B's for which convergence fails to occur has measure O under our choice of prior. 
Since our prior may assign measure zero to arbitrarily large subsets of Euclidean space, 
this convergence result is not entirely satisfactory and serves as a reminder to Bayesians 
that they should act conservatively and assign positive, if negligible, prior probability even 
to values of the parameter space which they regard as unlikely to occur. An extension of 
Doob's results to improper priors is given in Hartigan (1983). 
Since our best guess of Pn+m conditional on Yn is the current value Pn, enlarging the 
sample by m additional observations does not guarantee that our goal will necessarily be 
attained and may actually move us further away from it. However, by Jensen's inequality, 
PJ+m is a su bmartingale so that 
l/ ar[ Pn+m I Fn] = E[ PJ+m I Fn] - P~ (2.3) 
is nondecreasing in m and is actually strictly increasing when the sequence of conditional 
distributions is non-degenerate. It is exactly this increase in the variability of the predictive 
distribution that leads us to be hopeful that the goal may be reached by taking further 
observations. On the other hand, a bound to the probability of ever attaining our goal is 
provided by the Markov inequality, which implies that 
I - Pn [ ] Pn 1- l $P Pn+m~PIFn $-. 
-p p 
(2.4) 
For Pn smaller than p, the upper bound becomes sharp. This indicates that we may have 
little hope of reaching our goal if the interim posterior probability that g( 8) E G is way 
below the threshold value p2 ; a quite intuitive result that is also seen to be supported by the 
theory. Since Pn+m tends to IA a.s. Q as m increases, the limiting predictive distribution 
of Pn+m I Yn -is supported entirely on {O, 1} with masses depending on our current beliefs 
a.bout. g(8) being in G~ i.e. 
(2.5) 
as m --P oo, for all p E (0, 1). The above analysis suggests that there is a lot that we can 
say about the predictive distribution of Pn+m I Yn, without actually having to evaluate it. 
The results we will be presenting in the remainder of this paper are then only likely to be 
useful when Pn is smaller tha.n p but not by much and we are limited in the number of 
future observations that we can take. 
3 Approximating the predictive probability of success 
Let us pretend for a moment that the trial has been brought to its conclusion and Yn+m is 
actually available. The calculation. of P[g(8) E GI Yn+ml then simply requires the terminal 
posterior of g( 8). However, for censored data problems with nonconjugate priors, obtaining 
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this posterior in closed form is usually impossible. Although a naive approximation to the 
posterior could be based on a normal distribution with mean and covariance matrix deter-
mined by the first two derivatives of the log-posterior evaluated at its mode, for th~ sample 
sizes encountered in practice the normal approximation is likely to be grossly inadequate. 
Heavy censoring can drastically reduce the effective sample size and result in posterior dis-
tributions that exhibit substantial asymmetry. The Laplace approximation, proposed by 
Tierney & Kadane (1986), improves upon the normal approximation in that it can handle 
both skewness and kurtosis. Unfortunately, it is sensitive to all but mild multimodality. It 
can be shown, though, that for the generalised gamma distribution, a family that includes 
both the lognormal and the Weibull as special cases, there exists a parameterisation in 
which the log-likelihood is globally strictly concave. So, with flat priors, we need not be 
overly concerned about multimodality of the posterior, at least for this flexible family of 
lifetime distributions. 
The Laplace posterior requires numerical integration to find its normalising constant, 
with a separate constrained maximisation at each integration point. Even if the maximi-
sations converge, they tend to be quite costly to compute. What is worse from our point 
of view, in the usual case where the parameter space E> is unbounded we have to trun-
cate it for integration purposes to an interval that contains essentially all the probability 
mass. But, the truncation limits will differ from sample to sample and can only be obtained 
graphically, by visual examination of the unnormalised posterior. This requires interaction 
with the user, which one would rather avoid. A reparameterisation may transform E> to 
a bounded interval, but the Laplace approximation usually performs best when it is left 
unrestricted. There is, however, a way out of this conundrum: by careful examination of 
the error rates, derived in Kass et al. (1990), it is possible to show that the Laplace approx-
imation can be replaced by its Edgeworth-type expansion around the posterior mode with 
no addition~ l(?SS of accuracy, at least in O ((n + m)-1!2) neighborhoods of the mode. 
Once an Edgeworth-type expansion is available, it can be integrated asymptotically and 
third order approximations to credible intervals, quantiles, moments etc. can be easily 
found using standard procedures such as Cornish-Fisher inversion. Alternatively, densities 
from well-known distributions can be fit by matching either the first four derivatives at the 
mode, or the first four cumulants. Credible intervals would then be immediately available 
from standard computer packages. The first approach has been advocated by DiCiccio et 
al. (1990, 1991), while the second is closer to the recommendations of Viveros and Sprott 
(1987). Papandonatos & Geisser (1997) have examined both approaches in the context of 
linear regression models with possible censoring and have shown that impressive accuracy 
can be attained, even for terminal sample sizes as small as fifteen. 
At the interim stage only the first n observations will be available to us. The remaining 
m will have to be simula.ted from the predictive distribution of Ym I Yn· Since this can 
be represented as mixture over E> of the sampling densities of Ym I 6, with the interim 
posterior 8 I Yn as the mixing measure, one needs to be able to draw samples from p(B I Yn)-
Typically, the subsequent generation of log-lifetimes from P(Ym I 8) is trivial or at least 
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well-documented in the literature. However, censoring and the possible lack of conjugacy 
of the prior usually render the posterior intractable and require the use of Markov Chain 
Monte Carlo techniques, a comprehensive survey of which appears in Tierney (1994). 2 
Once the terminal posterior mode Bn+m has been located, P[g( 8) E G I y n+mJ can be 
approximated by expanding the terminal posterior of g(8) around g(Bn+m), as in Papando-
natos & Geisser {1997). When the size of the future sample is small relatively to that of the 
initial sample and stage II is short in duration, we would expect p(8 I Yn) and p(8 I Yn+m) to 
be similar. In that case, Bn+m will not differ substantially from Bn, the posterior mode at 
the interim stage, which can then serve as the starting value for the Newton iteration. On 
the other hand, if m/n is large and stage II is long enough for only a few of the participants 
to remain a.live at the end of the experiment, we would expect Bn+m to be closer to Bm, the 
simulated value of 8 that was used to generate both them lifetimes of the future sample 
and the latent lifetimes of the stage I survivors. A weighted average of Bn and Bm can then 
be used to initialise Newton's algorithm, with the weights chosen empirically to reflect both 
the relative sample sizes and the degree of censoring. We have found that a matrix weighted 
average with weights equal to the information matrices for the original and future samples, 
evaluated at the interim posterior mode and the simulated value of 8 respectively, is quite 
adequate in this respect. 
4 Simulating tbe final stage of trial 
For convenience we shall treat the data as representing individual lifetimes and let T n = 
(Td, Tc, T,) denote then-vector of times under observation of the d individuals in the initial 
sample that died during stage I, those c whose observation ceased at or prior to the interim 
point and the l survivors that enter stage II respectively. Since we allow staggered entry into 
the trial, the. ce~soring times may all differ, even if observation of the initial sample ceases 
at the same time point for all individuals in it. At the end of the trial, the data on which we 
will base our inferences for g(8) can be similarly partitioned into 'I'n+m = {Td, Tc, T,, Tm), 
where T, denotes time under observation during the entire trial for those stage I survivors 
that remain under observation in stage II and Tm is the time under observation of the m 
individuals of the future sample. 
It is assumed that the actual lifetimes are conditionally independent given 8 and that the 
distribution of their natural logarithm can be adequately described by the linear regression 
model 
log L = 80 + 8[ w + Z exp 82, 
with the intercept 00 , the slope vector 81 and the logscale parameter 02 making up the 
2 All of the above are predicated on a fixed design on s individuals. In trials "to learn", we would first 
have to approximate the preposterior distribution of the Lindley Information Measure in order to find s. The 
same methods used in sampling from 91 y, would also be applicable with y, drawn from its prior predictive 
distribution, assuming it is proper. 
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parameter vector 8. In addition, the error distribution Fz( z) will be taken as known. An 
estimate of P [ P [ g( 8) E G I 'I' n+m ] ~ p I T n] can then be obtained as follows: 
1 G T.' 1 T-(l) T-(K) f h di ' d' 0 b • f T- IT . enerate .d. samp es n+m, ... , n+m rom t e pre ct1ve 1stri ut1on o n+m n· 
2. For the k'th sample calculate pk = P [ g( 8) E GI Ti~m] . 
3. Return Ef=i I { pk ~ p} / /(, together with an estimate of its standard error. 
We will first describe the simulation step in detail. In order to do so, we will employ 
bracket notation to denote densities, with the joint, conditional and marginal densities of 
two generic random variables U, V given by { U, V}, { U I V}, { U} respectively. In addition, 
the integral sign will imply marginalisation, so that J {U I V}{V} = {U}. It can then be 
shown that that the predictive density {'I'n+m I Tn} decomposes into 
Here {Td I Td}, {Tc I Tc} are point-mass distributions, while {T,, 'I'm I Td, Tc, T,} equals 
where L is the true lifetime · of an individual and C its censoring time at the terminal 
point. Since we only deal with noninformative censoring, we do not allow the distribution 
of C to depend on 8. By definition, 'I'= min(L, C) is a constant when both L, Care known, 
so we concentrate on the nondegenerate densities: 
1. {Lm I 8} : If we have access to a statistical package that allows us to sample from the 
error distribution Fz( z) directly, we can generate the loglifetimes of the future sample 
by a. locat1on-sca]e transformation of Z: Jog L = 00 + 8f w + Z exp 02 • 
2. {L, I 8, T,} : Since a.11 stage I survivors were censored at the interim point, we must 
left-truncate the usual sampling distribution of L, at T,. Although we could generate 
the individual lifetimes as in ( 1) and retain only those that satisfy the constraint, 
it is more efficient to use 1-1 inverse C.D.F. sampling by noting that the individual 
lifetimes are conditionally independent given 8 and satisfy 
Fz(z2) - Fz(z1) 
= 1- Fz(zi) ' 
with t2 ~ t 1 > 0 and 
Z1 = (log t1 - Bo - er w) exp(-82), z2 = (logt2 - Bo - er w) exp(-82). 
As in Devroye (1986), this can be done by generating U rv U(O, 1] and setting 
log L = Bo+ 8[ w + Fz1 ( Fz(z1) + U [1 - Fz(z1)]) exp 82, 
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assuming that the inverse of Fz( z) exists and is either available in closed form or can 
be approximated to the required accuracy by the computer package of our choice. 
3. { C1 I Ti} : In the examples we shall consider we will obtain C1 by adding t to each 
element of T1, where tis the duration of stage II of the experiment. A more realistic 
censoring scheme would also take into account losses to follow-up prior to the end of 
the trial, with the censoring mechanism possibly dependent on the covariates. 
4. { Cm } : We shall assume that all elements of the future sample will be placed under 
observation at exactly the same time point, to time units before the end of the trial. Cm 
will then be degenerate at to, 0 ~ t0 ~ t. In clinical trials such an assumption is often 
unrealistic and an attempt should be made to model patient accrual probabilistically 
and to incorporate losses to follow-up during stage II. 
5. {8 I Td, Tc, T,}: We will sample from the interim posterior of 8 by running a Metropo-
lis rejection independence chain, as described in Tierney (1994). If the envelope is in 
fact adequate, the method will produce independent draws from the exact posterior; 
otherwise the initial transient and the effect of dependence on standard errors will 
have to be taken into a.ccount. 
5 Conducting a Sensitivity Analysis 
Let us suppose that our client is a pharmaceutical company that will ultimately need to 
show to a regulatory agency that, in a trial in which at least s subjects were enrolled, 
administration of a new drug to the treatment group resulted in a median survival time 
at least r times as high as that of patients in the control group, with posterior probability 
in excess of a cutoff value p. To guard against possible side effects, which are of known 
severity for the standard treatment but not for the novel therapy, r will typically be strictly 
greater than unity with a whole range of values initially contemplated. Letting g( 8) denote 
the difference in the median loglifetimes between the two groups, the approximations in Pa-
pandonatos & Geisser (1997) require that the bulk of our computational efforts be directed 
towards calculating the first four derivatives at g(Bn+m) of the terminal posterior of g(8). 
Once these constants are in hand, the additional expense in letting r take multiple values 
will be minimal. This presents a clear advantage of our approach over that advocated by 
DiCiccio et al. (1990, 1991), when multiple tail areas need to be approximated. Similarly, 
we could vary p to see how sensitive our results are to requiring a more stringent level of 
confidence in our recommendations, at little further cost. A contour plot of the predictiye 
probability of success as a. function of J> and r would then provide a nice visual supplement 
to our analysis. The above analysis assumes that both t, the duration of stage II and m, 
the size of the future sample, are fixed in advance with only p, r allowed to vary. But, there 
is no reason not to allow t, m to depend on the information gathered during stage I as well. 
Of most interest here would be the trade-off between increasing the length of the trial and 
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about here 
increasing the number of participants. For regression problems where the covariate settings 
can be chosen at will we obviously have an intricate design problem in our hands, which 
will not be dealt with here. When we cannot exercise any control over the covariates of the 
incoming participants, but can describe their probability distribution instead, we can try to 
design a factorial experiment with several (t, m) combinations, to which a response surface 
methodology could then be applied. 
When m is fixed, a gradual increase in the time at which the imputed true lifetimes are 
being censored will lead to posterior modes that are not too far apart. These can then be 
used in succession as initial values for Newton's method. The same strategy can be used 
when we keep t fixed and slowly enlarge m. Since Newton's maximisation converges rapidly 
close to the maximum, but may encounter problems if a poor initial point is chosen, it is 
very encouraging to know that our starting values are likely to perform well. 
6 An Example: Pike's Carcinogenesis Data 
The data in table 1 come from a carcinogenicity experiment two groups of mice which has 
been reported in Pike (1966) and analysed extensively by Kalbfleisch & Prentice (1980). 
Since cancer occurs in a tissue when at least one of its cells becomes carcinogenic, Pike 
(1966) argued for a Weibull model for the time till cancer onset, due to the asymptotic 
derivation of the Weibull as the minimum of a large number of independent observations. 
The assumptions implicit in the analysis are that (i) death with tumor is equivalent to death 
from tumor, (ii) the tumor is rapidly lethal and (iii) eventually all mice will contract cancer, 
if they live long enough. As a result, mice that had not died at the time of the analysis or 
were tumor-free at death were regarded as censored observations. Following Kalbfleisch & 
Prentice (1980), we postulate a Weibull threshold model for the lifetimes in each group, and 
take the threshold and shape parameters to be common to the two groups, but allow the scale 
parameters to differ. If w were an indicator function denoting membership of the second 
group, our model would be equivalent to assuming that [A(L - TJ)/ pw]6 l'V exp(l), where A 
is the scale parameter of the first group and >../ p that of the second group. This would in 
turn imply that log( L - TJ) has a Gumbel( 80 + 81 w, exp 82 ) distribution where Bo = - log A, 
81 = log p and 82 = - log 8; a simple linear regression model to which the asymptotic 
approximations to marginal tail probabilities presented in Papandonatos & Geisser ( 1997) 
are applicable. Although their results can accommodate informative priors with ease, we 
will adopt a prior that is flat in the 8 parameterisation and which may be thought of as 
'noninformative' in the sense that it reproduces conditional frequentist inferences under 
Type II censoring. It differs from Jeffreys' prior, which turns out to depend on the design 
ma.trix and which requires more detailed assumptions about the censoring mechanism. 
The first group of mice has previously been analysed in a BaJesian predictive setting 
by Geisser (1993a.), whose analysis was performed conditionally on T/ = 100 and 8 = 3. We 
will also condition on 1J = 100, but allow 8 to be unrestricted, turning the problem into 
a bivariate one involving (J =- (Bo, 82) alone. The additional information on 82 provided 
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by the second group will be ignored at this stage. This way our approximations for stage 
II censoring can be compared to his exact results for an uncensored experiment, at the 
additional expense of a one-dimensional numerical integration. The observation 188 appears 
twice in the first group, but its second occurrence was apparently omitted by Geisser. To 
make our results comparable to his, we will also exclude it from our initial analysis, keeping 
it in reserve for a perturbation analysis later on. 
In order to illustrate the methodology outlined in earlier sections, we will first calculate 
the predictive probability that L.so, the median lifetime of the first group of mice, will exceed 
206 days with terminal posterior probability at least equal top, if observations are taken 
on m additional mice fort days. The hypothesis Ho : L.50~206 has an interim posterior 
probability of .907 and thus would be narrowly rejected in favour of H1 : L.50 < 206 by any 
Bayesian hypothesis testing procedure requiring odds at least 10:1 in favour of Ho for its 
acceptance. · 
Rather than focus on posterior odds alone, we may also want to impose the additional 
requirement that m and t should be chosen so as to virtually guarantee that a 99% equal 
tail terminal posterior interval for L.so will not exceed 45 days in length, down from 58.09 
at the interim stage. The equal tail interval is chosen in preference to an H.P.D. region 
both for computational convenience and also in order to penalise extreme skewness in the 
posterior of L.50 , of the kind that could result from sampling plans that lead to very heavy 
censoring. 
If we were to assume that the two mice censored at the interim stage were lost to follow 
up and that t was chosen long enough for all m. future observations to die, the expressions 
in Geisser (1993a) could be manipulated to yield via univa1fate numerical integration the 
exact predictive probability P[ P[ L.so ~ 206 I 'I'n+m] ~ p I Tn} for various finite values of 
m and of the cutoff point p. The results are shown in fig. 1, as m is increased from 1 to 
104 in power~ of 10. We see that even a single additional observation introduces a lot of 
uncertainty, moving us from a point mass distribution at .907 to one that spreads its mass 
over the interval (0.2, 1). As the size of the future sample is increased further, the curves 
gradually get closer to the horizontal asymptote at .907, but convergence is rather slow. 
A heuristic explanation for the limiting form of the predictive probability of eventual 
acceptance of Ho can be given by first noting that, if the future sample size m were to 
increase without bounds, the distribution of the median lifetime L.50 would tend to a point 
mass at some as yet unknown value. The best that can be said about this value at the interim 
stage is that it will exceed 206 days with probability .907. This would in turn suggest a 
discrete limiting predictive distribution for P[ L.so ~ 206 I 'I'n+mJ supported entirely on 
{0, 1} with weights .093 and .907 respectively. But then P[ P[ L.so ~ 206 I 'I'n+ml ~ p I Tn] 
should tend to .907 for all pin the interval (0, 1) in accord with result (2.5). 
In fig. 2 the value of pis increased from .65 to .95 in increments of .05, bringing out a 
fa.ct obscured in fig. 1: the convergence to the asymptote need not be monotonic. Indeed, 
for low values of ]J it is not monotonic and, rather than gaining anything by taking a future 
sample of moderate size, we wil1 proba.bly end up worse off tha.n if we took just a. few 
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extra observations. On the other hand, for high values of p, significant gains are within 
our reach even for small values of m. To better understand why this happens, we should 
remind ourselves that the interim posterior probability of Ho is .907 and any p < .907 
would have resulted in acceptance of Ho at the interim stage. It is then only natural that, 
by introducing uncertainty in the form of extra observations, we risk altering our conclusion 
in favour of H 1 • Similarly, any p > .907 would have led to rejection of HO at the interim 
stage and continuing the experiment gives us a chance to obtain a more favourable result. 
Although derived for an experiment with no second stage censoring, the exact results 
above are of some use to us in the case oft finite, since a decrease in the duration of the 
experiment can be thought of as equivalent to a reduction in the effective sample size. One 
can then identify a point in a particular curve, chose a fixed value of m and trace the 
predictive probability as m is decreased towards O to get a feel for the implications of a 
larger degree of censoring. For example, it is obvious from fig. 2 that an increase in the 
degree of censoring will have a much greater effect on the predictive probabilities at higher 
values of p, where there is more downswing potential. 
If we assume that our resources allow a maximum of m = 30 mice to be added to the 
first treatment group, our aim could be to find the shortest censoring time consistent the 
requirement that a 99% terminal posterior interval for L.50 be shorter than 45 days. This, 
in turn requires us to simulate future sample paths by drawing from the predictive density 
of 'I'n+m I Tn, which we will do by first getting a grip on the posterior of 8. 
Since p(8o I 82, Tn) is given in Geisser (1993a), in order to construct an adequate enve-
lope to p(8o, 82 I Tn) we only need to a good approximation to p(82 I Tn). Papandonatos & 
Geisser (1997) have shown that taking (82 + 1.227)/.548 to be distributed as the.logarithm 
of a F(827.524, 16.053) variable results in approximation indistinguishable from the true 
density to within plotting accuracy. Five hundred simulated 8 values are given in fig. 3, 
with .8, 0.5, .2, .01 and .001 contours of their exact scaled posterior superimposed. If we 
assume a xA) approximation to -2log [p(8 I Tn)/p(8 I Tn)], the ,'th contour of the scaled 
posterior corresponds to an approximate 1-1 joint credible interval. We thus conclude that 
our sample is evenly spread over the range of the parameter space receiving non-negligible 
posterior mass. 
In order to generate sa.m pies from the joint predictive density of the lifetimes of the future 
sample, we first notice that - conditional on 8 - the individual lifetimes are independent 
Weibull-distributed random variables. Therefore, they are exchangeable unconditionally 
and ha.ve the same marginal distribution, which can be approximated by a finite mixture 
of Weibull distributions evaluated at the simulated parameter pairs. The approximation is 
given in table 2 and reveals that there is no real need to consider experiments longer than 
twelve months in duration, since almost all the mice will have died by then. On the other 
hand, it seems that four months constitute the minimum duration required for obtaining 
additional information about the death times from the future sample. The expected num-
ber of deaths at any given censoring time does not, however, convey the whole picture, 
with censored observations possibly quite informative for the lower quantiles of the lifetime 
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distribution, but less so for the median. So, we also need to examine the simulated terminal 
posteriors of L.so directly and estimate selected quantiles of the predictive distribution of 
the length of a 99% terminal credible interval. 
This brings us to the most time-consuming part of the simulation: the maximisation of 
the five hundred simulated terminal posteriors, each one based on thirty additional lifetimes 
which are first truncated at t and then combined with the initial sample. The maxima for 
four selected second stage durations t are plotted in fig. 4. A comparison of figs. 3 and 4 
shows a tendency for the maxima to shrink the simulated parameter pairs used in generating 
the m future lifetimes towards the mode Bn of the interim posterior, the degree of shrinkage 
depending on the length of phase II. The longer tis, the more we learn about the simulated 
value Bm and the closer the terminal posterior mode moves towards it. Even for a fixed 
censoring time, it is apparent from the plots that the degree of shrinkage varies between 
the axes of the elHpse defined by the norma.l approximation to the interim posterior of 
8. An intuitive explanation is not hard to find: if we were to work in terms of centered 
and asymptotically uncorrelated coordinates, we would find them to be proportional to 
proportional to the . 7605 and .0001 quantiles of the loglifetimes. What the plots then tell 
us is that, as the degree of censoring increases, the terminal posterior mode of L.7605 is much 
closer to the interim mode than that of L.0001, which is pulled towards its simulated value. 
This makes sense, since heavy censoring allows to us to glean little new information about 
the seventy sixth percentile of the lifetime distribution, but quite a lot about the minimum 
possible death time. 
This observation argues a.ga.inst the use of convex combinations of Bn and Bm in ini-
tialising the Newton iteration. We found that a a matrix weighted average of Bn and Bm 
with weights given by the information in the likelihoods of the initial and future samples 
respectively performed better in this regard. When multiple censoring times are contem-
plated, all q~ite_ close to each other, a possible initialisation strategy would be to start the 
maximisations of each simulated terminal posterior at the smallest censoring time with the 
guess suggested above and then use the new mode as the best guess at the mode of the 
posterior that results when truncating the same imputed lifetimes at the immediately higher 
censoring time. In general we found that Newton's method converged in 3-5 iterations at 
the lowest censoring time and 1-2 iterations as t was subsequently increased by one mont.h 
at a time. 
e 
Once the posterior modes are in hand, the .005 and .995 quantiles of the normal and 
Laplace approximations to the marginal of L.so can be calculated with little additional 
computational effort. Their difference can be used in turn to calculate the predictive dis-
tribution of 99% terminal credible interval lengths, whose quartiles are shown in fig. 5. We 
immediately notice that the normal approximation has interquartile range similar to that 
of the Laplace approximation, but its median is lower, the difference increasing with the 
degree of censoring. The reason that the length distribution converges to a point mass at 
around 120 da.ys is that, with the expected number of uncensored observations close to 0, 
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all simulated terminal posteriors are almost identical. 
As for the probability of obtaining a terminal 99% interval no longer than 45 days, 
we present it in table 3. The results are very interesting, because they clearly show how 
misleading the normal approximation to the posterior of L .so can be for a sample size even 
as large as 48, when the degree of censoring is high. In particular, the normal approximation 
results would encourage us to curtail the experiment at six months, whereas the Laplace 
approximation indicates that a minimum of nine months is required for us to have a high 
degree of confidence in achieving the required interval length. It could be argued that 
early stopping is not of too strong a concern to a Bayesian, who, unlike a frequentist, 
may take multiple looks at the data without having to adjust the length of the credible 
intervals. Suppose, however, that the problem was not one of choosing between different 
values of t for the same m, but of varying m for a fixed t; then the inadequacies of the 
normal approximation would be more readily apparent: by misleading us into thinking that 
observing 30 mice over six months would be adequate, we would end up with an insufficiently 
informative experiment. If we then attempted to save the experiment by taking yet another 
sample of mice, we would have to wait at least another four months to observe any deaths 
and possibly seriously overrun our time schedule. 
In order to conduct a sensitivity analysis similar to the one in Geisser (1993a), we 
varied p from 0.65 to 0.95 in steps of 0.05 and obtained tables 4, 5, which approximate 
the predictive probability that P[ L.so ~ 206 I 'l'4s] ~ p with a standard error not exceeding 
0.02. Their last column pertains to an uncensored experiment and was calculated using the 
results in Geisser (1993a). 
A cursory compariso11 of the entries in tables 4, 5 shows that use of the normal approx-
imation results in mild overoptimism in ascertaining the probability of success at censoring 
times higher than seven months, while the picture is reversed for censoring times of seven 
months or lo:wei;. The discrepancy is not as remarkable as the one previously obtained for 
the oistribution of interval lengths; it increases with p but never exceeds 6%~ 3 It is also 
seen that, tha.t for p ~ .95, the odds of achieving our goal are at least 2: 1 in our favour for 
any experiment longer than seven months in duration and that an increase in· the length of 
the experiment from seven to twelve months brings only a negligible improvement in the 
odds of success. So, the critical factor in fixing the length of the second phase should be 
the probabi lity of obtaining a sufficiently informative sample, as determined by table 3. 
It is interesting that, even though the interim probability of Ho is just above .90, the 
predictive probability that this will be the case at the end of the more informative experi-
ment is only . 79. Still, there are sufficient grounds for being optimistic that we will be able 
to decide in favour of Ho at the end of the trial, for all values of p under consideration. 
3 When using the tables to estimate changes in the predictive probabilities as either port vary, it should 
be kept in mind that entries in t.be table should be positively correlated not only within the same row but 
also within columns, because the same future lifetimes were truncated at all eight censoring points to yield 
the simulated times under observation. This can be seen as an elementary attempt at variance reduction 
using common variates. 
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Finally, we examine the changes in the predictive probabilities if the extra observation 
at 188 days is included in the original sample and the two mice censored at the interim 
stage are assumed to have continued under observation, instead of being lost to follow-up. 
The predictive densities of the true lifetimes of the censored observations can be derived 
as mixtures of left-truncated Weibull distributions and suggest that the probability that 
either one observation is still surviving at the end of stage II is minute. Rather than re-
peating the time-consuming maximisations of the new terminal posteriors, one can find the 
new predictive probabilities by perturbing the original simulated posteriors, as outlined in 
Papandonatos & Geisser {1997). In addition to including the extra lifetime, this involves 
dropping the two censored observations, imputing their lifetimes and then recensoring them 
Tables 6, 7 according to the length of stage II. The results are given in tables 6, 7. Apart from the 
about here row corresponding top= .95, the entries of table 6 vary little from those of table 5. More 
significant is the increase in the informativeness of the experiment, as manifested by the 
higher probabilities of achieving a 99% terminal credible interval length of 45 days, what-
ever the censoring time. If our rule of the thumb is to set the censoring time to the smallest 
value consistent with a predictive probability of obtaining the desired interval length of at 
least .9, table 7 suggests that we can reduce t from 240 to 225 days if the extra three mice 
became a.vailable to observation during the final stage of the experiment, while maintaining 
the probability that P[ L.50 ~ 206 I '1\o] ~ p to within 2% of its original value at 240 days. 
Table 8 
about here 
Although the single group example is useful in that it allows us to compare the simulation 
results for stage II censoring to exact ones obtained for an uncensored experiment, a typical 
application of our methodology would involve the comparison of two treatments in terms 
of a parameter indicating treatment effectiveness, a setup not previously examined within 
a fully Bayesian predictive setting. 
In the G~1mpel regression model we introduced earlier in this section, p = exp( 81) is 
the ratio of the median lifetime in excess of 100 days for the second group to that of the 
first group and can thus be used as a criterion for comparing the two treatments. At the 
time of the interim analysis, this criterion would strongly favour the second treatment. 
Before pronouncing in its favour, however, we should note that two treatments are often 
considered equivalent if the ratio of the median lifetimes of the two groups falls with high 
posterior probability within a short interval centered at one. This approach is common 
in bioequivalence studies, in which a new drug formulation is being compared with an 
established standard with well-understood side-effects; one is understandably reluctant 
to abandon the better-known drug unless its competitor is demonstrably superior. The 
interim odds in favour of the second treatment regime when the equivalence zone is of the 
form ( 1 - h, 1 + h) are given in table 8 for some common choices of h. They are calculated 
by dividing the probability of exceeding the upper boundary of the equivalence zone by the 
probability of falling below it, using interim data on both groups of mice. Larger values of 
h correspond to increased conserva.tism on the part of the investigator, who may prefer to 
withhold judgment in either direction until additional information becomes available on the 
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two treatments. As can be found from the table, the interim probability that p exceeds one 
is .962, but that of p exceeding 1.20 is only .601, so that the introduction of an equivalence 
zone of 20% makes the choice between the two treatments much less clearcut. 
We will now assume that we require odds at least 10:1 in favour of the second treatment, 
with the treatments declared equivalent if the ratio of the median lifetimes in excess of 100 
days are within 10% of each other. Since no decision can then reached at the interim stage, 
it is of interest to us to predict whether observing an additional 60 mice for periods up 
to one year is likely to allow us to reach a conclusive result. Assuming that our resources 
do not allow larger scale experimentation, the trial would have to be abandoned if that 
predictive probability was small. Equalizing the sample sizes of the two groups produces 
a. predictive distribution for the termina.1 odds in favour of the second treatment whose 
quanti1es are given in ta.hie 9. Among the second stage durations we examined, the chances 
of obta.ining odds of at. least. 10: 1 in favour of the second trea.tment are better than even 
for all durations greater than seven months. However, although the predictive distribution 
rapidly acquires a long right tail, its lower quantiles also move away from the interim value 
of 27:5, with the first quartile eventually stabilising at odds of ar~und 7:2 after six months. 
This seems to imply that although there is considerable upswing potential, one must also 
accept the possibility that the final evidence in favour of the null hypothesis will be weaker 
than at the interim stage. In this sense, a prolongation of the trial does not allow us to 
sample to a foregone conclusion, but simply reflects an informed decision on our part to 
commit additional resources to demonstrating the effectiveness of a treatment regime we 
regard as sufficiently promising. 
As can b~ s~en from the credible intervals for the log-odds ratio traced out in fig. 6, 
both the variance and the right skewness of the predictive distribution increase with time. A 
strategy aimed at maximising the probability of accepting the hypothesis that the second is 
superior would then be to prolong the second stage duration for as long as it takes for all the 
additional mice to die, i.e. for a.pproxima.te]y one year. Indeed, we know from result (2 .. 5) 
tha.t, for a. large enough experiment~ the predictive probability of obtaining a.ny positive 
odds in favour of the second treatment should tend to P[p ~ 1.10 I T 40 ] = .843. As can be 
seen from table 10, a.n additional sample of 60 mice is not large enough to get us close to 
"this limiting value, but does approach it from below as the effective sample size increases, 
until it stabilises at around .60 for the essentially uncensored experiment of a one-year 
duration. Getting any closer to the limiting probability than that requires increasing the 
number of mice allocated to the two treatments, rather than simply prolonging the second 
stage of the experiment. Still, to the extent t"hat the intuition gained from fig. 2 is relevant 
to the current setting, it is likely that most of the gains from taking an additional sample 
ha.ve already been exhausted and that raising the predictive probability to .85 would require 
prohibitive increases in the size of the future sample. 
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7 Conclusions / Future Work 
In this paper we showed how a combination of simulation and analytic approximation can aid 
Bayesian interim analyses of Weibull-distributed lifetime data. Although our examples dealt 
only with right censoring, extensions to left and interval censoring are trivial to implement. 
The required expansions are also easy to obtain for other error distributions, but their 
adequacy needs to be examined case-by-case. The Laplace approximation may suffer when 
the likelihood is not strictly unimodal or the prior is in serious conflict with the data. 
The bulk of the computation effort required for our analysis is directed towards the 
maximisation of the simulated terminal posteriors. Since the convergence of Newton's 
method is quadratic in a neighbourhood of the mode and occurs in a single step when 
the contours are elliptical, good initial estimates of the mode and parameterisations that 
lead to near-normal posteriors can drastically reduce computation time. More experience 
with problems of this kind may allow us to suggest starting values better than the matrix 
weighted average that we employed. Even more promising are variance reduction techniques 
that allow us to obtain precise estimates of the predictive probabilities of reaching our goal 
using only a small number of simulated terminal posteriors. 
Alterna.tive pa.ra.meterisations should also be considered, with their effect on the sim-
ula.tions, maximisa.t.ions a.nd analytic expa.nsions assessed separately. There is no reason 
why the same parameterisation should be optimal for all of the above, though globally 
log-concave likelihoods with 11early elliptical contours are always a boon. 
Other design criteria may also be entertained. When the variance of the parameter de-
noting treatment effectiveness increases with its mean, relative rather than absolute length 
of terminal posterior intervals could be used in designing the experiment. Alternatively, our 
analysis could focus on the posterior probability of the hypothesis of interest alone, calcu-
lated under a range of priors ranging from the optimistic to the sceptical, as recommended 
by Spiegelhalter & Freedma.n (1994). This assumes that we neither engage in continuous 
monitoring of the <la.ta nor have freedom in setting the levels of the covariates. Too much 
latitude in this respect would result in a huge increase of the computational burden, that 
cannot be realistically handled at this point in time, but may be more readily entertained 
in the near future, with the advent of massively parallel computers. 
In summary, the promise held by Bayesian interim analysis of regression models with 
possible censoring has not yet been fully realised, but the results to date seem sufficiently 
encouraging to justify further research in this area. 
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Table 1: Days to vaginal cancer mortality in mice after carcinogenic insult. 
Group 1 143, 164, 188, 188, 190, 192, 206, 209, 213, 216, 
220, 227, 230, 234, 246, 265, 304, 216"', 244"' 
Group 2 142, 156, 163, 198, 205, 232, 232, 233, 233, 233, 233, 
239, 240, 261, 280, 280, 296, 296, 323, 204"', 344"' 
Data from Pike (1966). Asterisks denote censored observations. 
Table 2: Predictive distribution of the lifetime L of a future observation. 
I 120 150 180 210 225 240 270 360 
P[ L ~ l I Tis] .004 .049 .179 .409 .544 .674 .869 .996 
Table 3: Probability of meeting design criterion when mice are lost to follow-up. 
Approximation Length of Phase II in Days 
120 1-50 180 210 225 240 270 360 
Normal .00 .00 .95 .98 .97 .97 .98 .96 
La.pla.ce .OD .DO .37 .82 .88 .92 .94 .9.5 
Table 4: P[ P[ L.so ~ 206 I 'l'4s) ~ p I Tis]: Normal Approximation. 
p Length of Phase II in Days 
120 150 180 210 225 240 270 360 00 
.65 .98 .96 .94 .93 .92 .92 .92 .92 .90 
~10- .98 .94 .92 .91 .90 .91 .91 .91 .89 
.7,5 .97 .92 .89 .89 .89 .89 .89 .89 .88 
.80 .89 .88 .87 .87 .87 .86 .86 .86 .85 
.85 .89 .83 .83 .83 .83 .84 .84 .84 .82 
.90 .89 .71 .74 .78 .79 .80 .81 .81 .78 
.95 .00 .57 .61 .67 .70 .73 .74 .74 .72 
Table -5: P[ P[ L.so 2: 206 I T4s] 2: p I T 1s]: Laplace Approximation. 
J) Length of Phase II in Days 
120 150 180 210 225 240 270 360 00 
.65 .98 .97 .95 .93 .92 .92 .92 .92 .90 
.70 .98 .95 .93 .91 .90 .91 .91 .91 .89 
.75 .97 .92 .90 .89 .89 .89 .89 .89 .88 
.80 .89 .91 .88 .87 .86 .86 .86 .86 .85 
.85 .89 .84 .84 .84 .83 .83 .82 .82 .82 
.90 .89 .74 .76 .79 .79 .79 .79 .79 .78 
.95 .00 .58 .63 .67 .68 .68 .68 .68 .72 
Table 6: P[ P[ L.so ~ 206 I T49) ~ p I T19]: Laplace Approximation. 
p Length of Phase II in Days 
120 150 180 210 225 240 270 360 
.65 .98 .94 .93 .92 .91 .91 .91 .91 
.70 .95 .93 .91 .90 .89 .89 .90 .90 
.75 .93 .91 .89 .87 .87 .87 .87 .87 
.80 .90 .87 .85 .85 .85 .85 .85 .84 
.85 .88 .81 .81 .82 .82 .82 .82 .82 
.90 .51 .70 .75 .76 .11 .78 .77 .78 
.95 .00 .48 .63 .66 .67 .65 .64 .64 
Table 7: Proba.bilit.y of meet.ing design criterion when no mice are lost to follow-up. 
Length of Phase II in Days 120 150 180 210 225 240 270 360 
Laplace Approximation .00 .22 .67 .86 .92 .93 .96 .97 
Table 8: Interim odds in favour of treatment 2 vs. half-length of equivalence zone. 
h .20 .15 .10 .05 .01 .00 
P[p ~ 1 + h I T40] 1.51 2.78 5.38 11.18 21.23 25.12 
P[ p < 1 + h I T 40] 
Table 9: Predictive distribution of the terminal odds in favour of treatment 2. 
Quantile Length of Phase II in Days 
120 150 180 210 240 270 300 330 360 
.10 2.79 2.44 1.86 1.62 1.08 1.07 1.09 1.01 0.99 
.2.5 4.33 :3.91 3.50 3.53 3.66 3.55 3.62 3.53 3.49 
.50 6.36 6.72 7.14 9.71 13.21 16.54 17.84 20.72 21.92 
.75 8.79 10.57 1-5.2!> 29.27 61.93 110.83 157.64 167.68 171.69 
.90 11.93 16.-56 :32.84 119.30 419.30 1055.74 1718.76 1698.49 1944.89 
Ta.hie 10: Predi~tive probability that treatment 2 will be judged superior at termination. 
Length of Phase II in Days 120 150 180 210 240 270 300 330 360 
p [ P[p?: 1.10 I !100] ?: 10 I T40] 
P[ p < I.IO I T100] .18 .28 .38 .49 .55 .58 .59 .60 .60 
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